UMSTEAD JOHN W. V (Chief Financial Officer) sold 0.3% of their position (527.00 shares) of G1 THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/8/2024ACC: 0001562180-24-005656
Officer· Chief Financial Officer
Since Mar 2023
-527.00
Net shares
Net seller
$1.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
527.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−527.00
Price / share
$2.51
Trade value
$1.32K
% of position
0.3%
7/5/2024
188.25K→187.72K
Total
Net shares
−527.00
Net value
-$1.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/5/2024 | S · Sale | −527.00 | $2.51 | $1.32K | 0.3% | 188.25K | 187.72K |
| Total | −527.00 | -$1.32K | ||||||
Derivative Transactions0
No derivative transactions reported